Incannex Accelerates Sleep Apnea Drug After FDA Fast Track Win, Phase 2 Success
Incannex Healthcare receives FDA Fast Track Designation for IHL-42X sleep apnea treatment following positive Phase 2 results, plans optimized Phase 3 pathway.
IXHLPhase 2 clinical trialdrug development